Dr. Yahya Burak Atalay, MD

Dr. Atalay practices at Jamaica Hospital Medical Center in Jamaica, New York, part of MediSys Health Network.

Dr. Atalay's NPI, 1730592460, was assigned on June 10, 2014. Dr. Atalay graduated from Hacettepe University FOM in 2011. Dr. Atalay holds Illinois license 036170535.

Dr. Atalay's primary practice is Jamaica Hospital Medical Center, at 89th Avenue and Van Wyck Expressway, Jamaica, NY 11418 in Queens County. The practice phone is (718) 262-6000. Dr. Atalay also practices at Jamaica Hospital Medical Center, 89- Van Wyck Expy, Richmond Hill, NY 11418.

Dr. Atalay's primary practice is Jamaica Hospital Medical Center in Jamaica, New York, part of MediSys Health Network. Dr. Atalay is also affiliated with NewYork-Presbyterian/Weill Cornell Medical Center. The medical group on file is Jamaica Hospital Medical Center. Dmand AI also links Dr. Atalay to 3 more hospitals, 11 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Atalay practices, 6 sites in all. Vendor and product names are available with a free account.

Vascular neurology is Dr. Atalay's primary specialty in the NPI Registry, under taxonomy code 2084V0102X. Dr. Atalay is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Atalay's licenses on file in 7 states: Illinois, Colorado, New York, Pennsylvania, Texas, New Jersey and Wisconsin.

Dmand AI lists acute mini-stroke (TIA), cerebrovascular disease, lower back pain, thoracic spine disorders and vertigo among the conditions Dr. Atalay treats.

CMS data shows 21 Medicare services from Dr. Atalay across 1 procedure code in 2024, for 23 Medicare patients. Medicare paid $3,527 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 23 Medicare patients who saw Dr. Atalay in 2024. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.39, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Atalay's median patient age at 65, with 49% women.

In 2023, Dr. Atalay wrote 44 Medicare Part D claims. They cover 3 drugs, with $960 in total drug cost. In 2022, CMS named 77 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Atalay for performance year 2024, reported as part of a group. Dr. Atalay accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Atalay as offering telehealth.

Dmand AI links 7 papers to Dr. Atalay, published from 2012 to 2021. The most frequent topics are Cortical Spreading Depression, Brain Ischemia and Cerebrovascular Circulation. Dr. Atalay has published most often in J Cereb Blood Flow Metab. Dr. Atalay's most frequent co-authors are Cenk Ayata, MD, Hooman Kamel, MD and Alexander E. Merkler.

CMS Open Payments shows 45 general payments to Dr. Atalay from 13 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 100% of the total. Penumbra, Inc. paid the most, $973.

Dmand AI lists 4 awards for Dr. Atalay, most recently Travel Grant in 2018.

Dr. Atalay graduated from Hacettepe University FOM in 2011. Dr. Atalay is a member of AAN, AHA, Society of NeuroInterventional Surgery, Society of Vascular and Interventional Neurology and The European Society of Minimally Invasive Neurological Therapy.

Dr. Atalay is in network with 27 carriers, including Elevance, Aetna and HCSC. PPO plans come from the most carriers, 16. Check the plan with the practice before a visit.